Publikationen in Zusammenarbeit mit Forschern von University of Manchester (12)

2023

  1. Diminishing benefits of urban living for children and adolescents’ growth and development

    Nature, Vol. 615, Núm. 7954, pp. 874-883

2021

  1. Heterogeneous contributions of change in population distribution of body mass index to change in obesity and underweight

    eLife, Vol. 10

2019

  1. Erratum to: Germline variation at 8q24 and prostate cancer risk in men of European ancestry (Nature Communications, (2018), 9, 1, (4616), 10.1038/s41467-018-06863-1)

    Nature Communications

  2. Rising rural body-mass index is the main driver of the global obesity epidemic in adults

    Nature

2018

  1. Authors’ response to the Comments from S.M.J. Mortazavi regarding: “Occupational exposure to high-frequency electromagnetic fields and brain tumor risk in the INTEROCC study: An individualized assessment approach”

    Environment International

  2. Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants

    Nature Communications, Vol. 9, Núm. 1

  3. Germline variation at 8q24 and prostate cancer risk in men of European ancestry

    Nature Communications, Vol. 9, Núm. 1

  4. Occupational exposure to high-frequency electromagnetic fields and brain tumor risk in the INTEROCC study: An individualized assessment approach

    Environment International, Vol. 119, pp. 353-365

2017

  1. Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults

    The Lancet, Vol. 390, Núm. 10113, pp. 2627-2642

2014

  1. Dabigatran - a continuing exemplar case history demonstrating the need for comprehensive models to optimize the utilization of new drugs

    Frontiers in Pharmacology, Vol. 5 JUN

2013

  1. Dabigatran - A case history demonstrating the need for comprehensive approaches to optimize the use of new drugs

    Frontiers in Pharmacology, Vol. 4 MAY

  2. Personalizing health care: Feasibility and future implications

    BMC Medicine, Vol. 11, Núm. 1